These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc. Coghlan VM, Vickery LE. J Biol Chem; 1991 Oct 05; 266(28):18606-12. PubMed ID: 1917982 [Abstract] [Full Text] [Related]
8. Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. Wada A, Waterman MR. J Biol Chem; 1992 Nov 15; 267(32):22877-82. PubMed ID: 1429635 [Abstract] [Full Text] [Related]
9. Adrenodoxin-cytochrome P450scc interaction as revealed by EPR spectroscopy: comparison with the putidaredoxin-cytochrome P450cam system. Takeuchi K, Tsubaki M, Futagawa J, Masuya F, Hori H. J Biochem; 2001 Dec 15; 130(6):789-97. PubMed ID: 11726279 [Abstract] [Full Text] [Related]
10. An additional electrostatic interaction between adrenodoxin and P450c27 (CYP27A1) results in tighter binding than between adrenodoxin and p450scc (CYP11A1). Pikuleva IA, Cao C, Waterman MR. J Biol Chem; 1999 Jan 22; 274(4):2045-52. PubMed ID: 9890963 [Abstract] [Full Text] [Related]
20. Construction and function of fusion enzymes of the human cytochrome P450scc system. Harikrishna JA, Black SM, Szklarz GD, Miller WL. DNA Cell Biol; 1993 Jun 02; 12(5):371-9. PubMed ID: 8517924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]